Reinforcement of Oral Epithelial Barrier Function by Vitamin D Induction of the Antimicrobial Peptide Cathelicidin. A Novel Therapeutic Approach in Chronic Periodontitis
Author(s) -
Aditi Bose,
H. N. Santosh
Publication year - 2021
Publication title -
journal of pharmaceutical research international
Language(s) - English
Resource type - Journals
ISSN - 2456-9119
DOI - 10.9734/jpri/2021/v33i63a36095
Subject(s) - cathelicidin , vitamin , vitamin d and neurology , medicine , calcitriol receptor , antimicrobial peptides , periodontitis , antimicrobial , chronic periodontitis , pharmacology , biology , microbiology and biotechnology
Oral epithelium forms a physical, chemical and immunological barrier against the invading microorganisms. The chemical barrier mainly comprises of anti-microbial peptides (AMPs) like cathelicidins which are endogenously produced antibiotics. Transcription of the cathelicidin anti-microbial peptide (CAMP) gene is induced by binding of the bioactive form of vitamin D to the vitamin D receptor. Thus, an increase in vitamin D should significantly improve the chemical barrier function by increasing AMPs.
Through a randomized controlled trial we tend to explore a well accepted molecule like vitamin D in primary prevention of chronic periodontitis by reinforcing the oral epithelial barrier by increased action of cathelicidin.
Aim of the Study: The aim of this study was to assess the effect of vitamin D administration systemically on levels of cathelicidin LL-37 in gingival crevicular fluid of chronic periodontitis patients.
Methodology: 40 vitamin D insufficient subjects with chronic periodontitis were divided into 2 groups. Gingival crevicular fluid (GCF) sampling was carried out a day after the periodontal examination. Next all patients were subjected to scaling and root planning (SRP). Test group patients were prescribed oral dose of 2000IU Vitamin D daily for a period of 3months whereas control group was devoid of any medication. GCF sampling was repeated for both the groups after three months. Cathelicidin LL-37 level was estimated using Enzyme Linked Immunosorbent Assay (ELISA)method for both the groups.
Results: Vitamin D administration increases the levels of cathelicidin in periodontal diseases. Cathelicidin levels in GCF increase after Vitamin D intake.
Conclusion: Periodontal diseases might be prevented by reinforcing the oral epithelial barrier (chemical barrier) by vitamin D induced production of AMPs.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom